Opinion
Video
Author(s):
Michael Leung, PharmD, presents the case of a 57-year-old man with cecal colon adenocarcinoma and provides his initial thoughts, particularly on adverse event management.
V. Craig Jordan, PhD, the ‘Father of Tamoxifen,’ Dies at 76
Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma
FDA Advises Against Accelerated Approval Pathway for Botensilimab/Balstilimab in R/R MSS CRC
Lenz Discusses the Prognostic and Predictive Value of HER2 Gene Expression in KRAS Wild-Type mCRC
Ibrutinib Plus Venetoclax Generates Durable CRs in TP53+ Mantle Cell Lymphoma
Real-World and Post-Hoc Analyses Support Luspatercept Use in Low-Risk Myelodysplastic Syndrome
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC
Dr Herbst on the Importance of Multidisciplinary Collaboration in NSCLC